Merrimack Pharmaceuticals (NASDAQ:MACK)

CAPS Rating: 5 out of 5

Recs

0
Player Avatar jhingston (< 20) Submitted: 8/1/2012 11:29:36 AM : Outperform Start Price: $8.02 MACK Score: -38.07

Business structure and financing plan

Featured Broker Partners


Advertisement